USCOM Ltd
UCM
Company Profile
Business description
USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. The company generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology.
Contact
66 Clarence Street
Suite 2, Level 8
SydneyNSW2000
AUST: +61 292474144
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees
11
Stocks News & Analysis
stocks
An undervalued stock to buy that even Warren Buffett likes
Trading at an 18% discount, this wide-moat stock is a rare find.
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,841.20 | 55.80 | -0.63% |
| CAC 40 | 8,081.43 | 41.98 | -0.52% |
| DAX 40 | 25,266.53 | 144.10 | -0.57% |
| Dow JONES (US) | 51,349.98 | 161.61 | -0.31% |
| FTSE 100 | 10,679.99 | 25.27 | -0.24% |
| HKSE | 24,333.52 | 427.61 | -1.73% |
| NASDAQ | 26,939.37 | 3.34 | 0.01% |
| Nikkei 225 | 66,318.14 | 804.15 | 1.23% |
| NZX 50 Index | 13,805.35 | 19.48 | -0.14% |
| S&P 500 | 7,704.13 | 1.90 | -0.02% |
| S&P/ASX 200 | 8,658.10 | 43.90 | -0.50% |
| SSE Composite Index | 3,888.37 | 48.15 | -1.22% |